Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.

Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, Takane H, Irie S, Kusuhara H, Urasaki Y, Urae A, Higuchi S, Otsubo K, Sugiyama Y.

Clin Pharmacol Ther. 2003 Jun;73(6):554-65.

PMID:
12811365
2.

Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.

Kivistö KT, Niemi M.

Pharm Res. 2007 Feb;24(2):239-47. Epub 2006 Dec 20. Review.

PMID:
17177112
3.
4.

The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.

Romaine SP, Bailey KM, Hall AS, Balmforth AJ.

Pharmacogenomics J. 2010 Feb;10(1):1-11. doi: 10.1038/tpj.2009.54. Epub 2009 Nov 3. Review.

PMID:
19884908
5.

Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Neuvonen PJ, Backman JT, Niemi M.

Clin Pharmacokinet. 2008;47(7):463-74. Review.

PMID:
18563955
6.

The functional consequences of genetic variations in transporter genes encoding human organic anion-transporting polypeptide family members.

Seithel A, Glaeser H, Fromm MF, König J.

Expert Opin Drug Metab Toxicol. 2008 Jan;4(1):51-64. doi: 10.1517/17425255.4.1.51 . Review.

PMID:
18370858
7.
8.
10.

Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.

Smith NF, Figg WD, Sparreboom A.

Expert Opin Drug Metab Toxicol. 2005 Oct;1(3):429-45. Review.

PMID:
16863454
11.

Statin dose in Asians: is pharmacogenetics relevant?

Wang P.

Pharmacogenomics. 2011 Nov;12(11):1605-15. doi: 10.2217/pgs.11.98. Review.

PMID:
22044416
12.

[Drug transporter studies in drug discovery and development].

Mizuno N, Niwa T.

Nihon Yakurigaku Zasshi. 2005 Apr;125(4):200-6. Review. Japanese. No abstract available.

PMID:
15930796

Supplemental Content

Support Center